Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang

Indoco Remedies | CMP: Rs 359 | The stock ended in the green after net profit of the firm was up 19.2% at Rs 49.7 crore against Rs 41.7 crore (YoY). Revenue rose 11.9% at Rs 433 crore against Rs 386.8 crore (YoY) while EBITDA gained 1.6% at Rs 87.7 crore against Rs 86.3 crore (YoY).

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Nirmal Bang has come out with its third quarter (October-December’ 23) earnings estimates for the PHARMACEUTICAL sector. The brokerage house expects Indoco Remedies to report net profit at Rs 482 crore up 46.1% year-on-year (down 3.1% quarter-on-quarter).

Net Sales are expected to increase by 18.3 percent Y-o-Y (down 2.2 percent Q-o-Q) to Rs 4,236 crore, according to Nirmal Bang.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 15.4 percent Y-o-Y (down 3.6 percent Q-o-Q) to Rs 847 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Nirmal_Pharmaceutical